Damora Therapeutics (DMRA) Short Interest
Nasdaq • DMRA • KYG2646Y1044
As of Oct 21, 2026, ORTEX estimated 11.4% of free float sold short, 8.6 days to cover, cost to borrow 1.96%. Sign up for live short interest data.
Nasdaq • DMRA • KYG2646Y1044
As of Oct 21, 2026, ORTEX estimated 11.4% of free float sold short, 8.6 days to cover, cost to borrow 1.96%. Sign up for live short interest data.
This page tracks how heavily Damora Therapeutics (Nasdaq:DMRA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Damora Therapeutics (Nasdaq: DMRA) has a market capitalization of $1.42B. Last close $22.94 (as of 2026-11-05); 52-week range $4.95 to $38.33. ORTEX data as of 2026-10-21: short interest was 11.43% of free float, 8.6 days to cover and the average cost to borrow was 1.96%. Sign up for live short interest data.